Noor Tayyab, Imran Ayisha, Raza Hassan, Umer Shereen, Malik Nomaan Aslam, Chughtai Akhtar Sohail
Haematology, Chughtai Lab, Lahore, PAK.
Hematopathology, Chughtai Lab, Lahore, PAK.
Cureus. 2023 Jan 31;15(1):e34444. doi: 10.7759/cureus.34444. eCollection 2023 Jan.
Introduction The Chughtai Laboratory collects blood samples for complete blood counts from various hospitals, emergency departments, ICUs, and through home sampling services all across the country. The preanalytical phase is an integral component of laboratory medicine. A laboratory report has a key role in patient treatment and the clinician's decision in the management of the disease. Preanalytical errors are most frequently caused by the absence of a sample and/or inappropriate understanding of a test request, mislabeling, contamination from the sampling site, hemolyzed, clotted, insufficient samples, storage issues, and inappropriate blood to anticoagulant proportion or inappropriate choice of anticoagulant. Objective To identify the cause of rejection rates of the complete blood count samples and reduce the rejection rates by improving the accuracy of the results and lowering pre-analytical errors. Methods This cross-sectional study was done in the Hematology Department of Chughtai Laboratory's head office in Lahore between 19-06-2021 and 19-10-2021. Simple random sampling was applied to collect the data. About 3 ml of each blood sample was received in an ethylenediaminetetraacetic acid (EDTA) vial, inspected visually, run on Sysmex XN-9000 (Sysmex Corporation, Kobe, Hyogo, Japan), and was reviewed on peripheral smears. Results Out of 231,008 blood samples, 11,897 (5.15%) samples were rejected. The most common pre-analytical mistake was storage issues due to transportation delay (19.45%) followed by wrong medical records (19.16%), diluted samples (16.35%), incorrect tubes (16.01%), hemolyzed samples (15.13%), unlabeled samples (10.01%), and clotted sample (3.88%). Conclusion In the hematology department, the total rejection rate observed during the study period was 5.15%. Recognition of preanalytical errors and avoiding them will help us lower the sample rejection rate and raise the overall quality of laboratory management.
引言
楚格泰实验室从全国各地的各类医院、急诊科、重症监护室以及通过上门采样服务收集全血细胞计数的血样。分析前阶段是检验医学的一个重要组成部分。实验室报告在患者治疗以及临床医生对疾病的管理决策中起着关键作用。分析前误差最常见的原因是样本缺失和/或对检验申请理解不当、标签错误、采样部位污染、溶血、凝血、样本不足、储存问题以及血液与抗凝剂比例不当或抗凝剂选择不当。
目的
确定全血细胞计数样本拒收率的原因,并通过提高结果准确性和降低分析前误差来降低拒收率。
方法
本横断面研究于2021年6月19日至2021年10月19日在拉合尔楚格泰实验室总部的血液科进行。采用简单随机抽样收集数据。每个血样约3毫升收集于乙二胺四乙酸(EDTA)瓶中,进行目视检查,在Sysmex XN - 9000(Sysmex公司,日本兵库县神户市)上运行,并对外周血涂片进行复查。
结果
在231,008份血样中,有11,897份(5.15%)样本被拒收。最常见的分析前错误是运输延迟导致的储存问题(19.45%),其次是错误的病历(19.16%)、稀释样本(16.35%)、错误的试管(16.01%)、溶血样本(15.13%)、未标记样本(10.01%)和凝血样本(3.88%)。
结论
在血液科,研究期间观察到的总拒收率为5.15%。识别并避免分析前误差将有助于我们降低样本拒收率并提高实验室管理的整体质量。